Table: Sapporo Clinical Lab -2023/24 parent results

Sapporo Clinical Laboratory

13/05/2024 07:30

May 13 (Reuters)- 
          Sapporo Clinical Laboratory Co Ltd 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to     NEXT     
              Mar 31, 2024    Mar 31, 2023   Mar 31, 2025     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           17.33           17.61          17.42         8.66    
               (-1.6 pct)      (-0.7 pct)     (+0.5 pct)    (+0.1 pct) 
  Operating      368 mln         705 mln                               
               (-47.7 pct)     (-51.8 pct)                             
  Recurring      598 mln         895 mln        500 mln      231 mln   
               (-33.2 pct)     (-42.9 pct)    (-16.4 pct)  (-35.9 pct) 
  Net            460 mln         471 mln        334 mln      153 mln   
               (-2.4 pct)      (-53.9 pct)    (-27.4 pct)  (-48.0 pct) 
  EPS          138.25 yen      141.47 yen     106.83 yen    49.21 yen  
  Ann Div       23.00 yen       23.00 yen      23.00 yen               
  -Q2 Div          NIL             NIL            NIL                  
  -Q4 Div       23.00 yen       23.00 yen      23.00 yen               
  
  NOTE - Sapporo Clinical Laboratory Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=9776.T